ValGenesis | $16,000,000 | (Jul 23, 2025)
AbsoluteCare | $135,000,000 | (Jul 23, 2025)
Phlow | $37,000,000 | (Jul 23, 2025)
Certified by Founder
Lodge
Moonwalk Biosciences
start up
United States
- South San Francisco, California
- 08/01/2024
- Series A
- $57,000,000
Moonwalk Biosciences is an early-stage therapeutics company co-founded by Dr. Feng Zhang and leading experts in cell state epigenetics including Alex Aravanis, the former CTO of Illumina. The company has developed a differentiated approach to mapping the epigenome of cellular states at the whole genome, single cell resolution level, as well as proprietary strategies for precise epigenetic engineering. The combination enables both a novel discovery platform and a path to developing therapeutics that include both epigenetic engineering and other traditional modalities.
- Industry Biotechnology Research
- Website https://moonwalk.bio/
- LinkedIn https://www.linkedin.com/company/moonwalk-biosciences/about/
Composio | $25,000,000 | (Jul 23, 2025)
Nevoya | $9,300,000 | (Jul 23, 2025)
Delve | $32,000,000 | (Jul 23, 2025)
CandorIQ | $4,800,000 | (Jul 23, 2025)
BetterComp | $33,000,000 | (Jul 23, 2025)
Glīd | $3,100,000 | (Jul 22, 2025)
Cooler Heads Care | $11,000,000 | (Jul 22, 2025)
Alix | $20,000,000 | (Jul 22, 2025)
Nexxa.ai | $4,400,000 | (Jul 22, 2025)